This document is a financial statement for Ghislaine Maxwell's account at J.P. Morgan for the period of March 2014. It includes an equity summary and detail of asset categories, specifically EAFE Equity, with beginning and ending market values, changes in value, and current allocation. The equity detail lists specific assets such as GlaxoSmithKline PLC, Kirin Holdings Company Ltd, and Reckitt Benckiser Group PLC, with their respective prices, estimated annual income, and yield.
documents/vol00010-efta01519530-pdf.pdf
{"title":"Equity Summary and Detail for Ghislaine Maxwell","key_people":["Ghislaine Maxwell"],"document_date":"2014-03","document_type":"tabular","document_subtype":"financial statement","key_organizations":["J.P. Morgan","GlaxoSmithKline PLC","Kirin Holdings Company Ltd","Reckitt Benckiser Group PLC"],"reference_numbers":["37733W-10-5","497350-30-6","756255-20-4"]}